|By Marketwired .||
|July 14, 2014 09:39 AM EDT||
DUBLIN, IRELAND -- (Marketwired) -- 07/14/14 -- Research and Markets (http://www.researchandmarkets.com/research/n9nr3l/specialty_enzymes) has announced the addition of the "Global Specialty Enzymes Market Forecasts & Opportunities, 2018" report to their offering.
Specialty enzymes are natural proteins produced from microorganisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others.
Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail.
The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches.
Specialty enzyme usage in the pharmaceutical industry is mainly for drug manufacture, disease diagnostics, or as therapy. Increasing implication of enzymes in therapies for diseases such as cancer, cardiovascular diseases, lysosomal storage disorders, pain and inflammation management, among others, is a tidal force that fuels market demand. Enzyme demand in the research and biotechnology end-market would benefit from the fall in DNA sequencing costs and the increase of new sequencing techniques.
The vast majority of enzymes used in research and biotechnology, which spans over 80%of the demand, are devoted to DNA amplification and sequencing. This segment is led by DNA polymerases, which has experienced strong growth as new DNA sequencing techniques have been developed in recent years and the cost of DNA sequencing has dropped dramatically. The number of investigations is expected to increase, creating a strong business case for specialty enzymes.
Scope of the Report
-- Carbohydrases -- Protease -- Polymerases and Nucleases
-- Pharmaceuticals -- Biocatalysts -- Diagnostics -- Research & Biotechnology
-- Microorganisms -- Plants -- Animals
-- Advanced Enzyme Technology Ltd. -- Affymetrix Inc. -- Amano Enzyme Inc. -- Basf -- Bbi Enzymes Ltd. -- Codexis Inc. -- Life Technologies -- Nagase & Co. Ltd. -- Roche Holding Ag. -- Sanofi S.A.
For more information visit http://www.researchandmarkets.com/research/n9nr3l/specialty_enzymes
Sector: Process and Materials
Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Process and Materials include:
-- BASF SE -- Nike, Inc -- E. I. du Pont de Nemours and Company (DuPont) -- The China National Publications Import & Export Corporation (CNPIEC) -- Lenzing AG -- Exxon Mobil Corp. -- Bayer AG -- Honeywell International, Inc. -- Bio Springer -- Poyry -- Evonik Industries -- SABIC -- SI Group -- Osaka Gas Chemicals Group -- Gowan Company LLC -- The Lubrizol Corporation -- Koppers Inc.
Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716